Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mizuho Terada"'
Abstract P3-13-02: Safety and Efficacy of Zoledronic Acid Beyond 24 Months in Breast Cancer Patients
Autor:
Naoki Niikura, Yuki Saito, Toru Morioka, Rin Ogiya, Yutaka Tokuda, Banri Tsuda, Risa Oshitanai, Mayako Terao, Mizuho Terada, Yasuhiro Suzuki, Takuho Okamura
Publikováno v:
Cancer Research. 72:P3-13
Background: Bisphosphonate therapy has decreased the risk of skeletal complications associated with osteolytic bone lesions in patients with breast cancer and multiple myeloma. The large prospective studies have used 21 to 24 months of treatment. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd1a8968790fcc3981134eb05fbf6e55
https://doi.org/10.1158/0008-5472.sabcs12-p3-13-02
https://doi.org/10.1158/0008-5472.sabcs12-p3-13-02
Autor:
Shinobu Umemura, Yasuhiro Suzuki, Risa Ohshitanai, Naoki Niikura, Takuho Okamura, Yutaka Tokuda, Tohru Morioka, Yuki Saito, Banri Tsuda, Mayako Terao, Mizuho Terada
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 21:78-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f25fcc75ba0911849ec1d88ea4a467f
https://doi.org/10.3804/jjabcs.21.78
https://doi.org/10.3804/jjabcs.21.78
Autor:
Yuki Saito, Banri Tsuda, Risa Oshitanai, Mayako Terao, Mizuho Terada, Takuho Okamura, Yasuhiro Suzuki, Yutaka Tokuda
Publikováno v:
Japanese Journal of Clinical Oncology
Objective: The purpose of this study was to assess the safety of S-1 in Japanese in inoperable or recurrent breast cancer patients. Methods: A prospective post-marketing surveillance was performed at 313 sites in Japan in patients with inoperable or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c782a4b993258bd451cbd27c3f1c12
https://doi.org/10.1093/jjco/hyr099
https://doi.org/10.1093/jjco/hyr099
Autor:
Mizuho, Terada, Naoki, Niikura, Banri, Tsuda, Shinobu, Masuda, Nobue, Kumaki, Xiaoyan, Tang, Takuho, Okamura, Yuki, Saito, Yasuhiro, Suzuki, Yutaka, Tokuda
Publikováno v:
The Tokai journal of experimental and clinical medicine. 39(3)
Intraoperative sentinel lymph node (SLN) biopsy is widely used in patients with early-stage breast cancer and is conventionally performed using hematoxylin and eosin-based histological examination. The one-step nucleic acid amplification (OSNA) assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ede5840807a5e5c3bd5bf4b5c3323b14
https://pubmed.ncbi.nlm.nih.gov/25248427
https://pubmed.ncbi.nlm.nih.gov/25248427
Autor:
Naoki Niikura, Banri Tsuda, Rin Ogiya, Toru Morioka, Takuho Okamura, Yasuhiro Suzuki, Yuki Saito, Yutaka Tokuda, Risa Oshitanai, Mayako Terao, Mizuho Terada
Publikováno v:
International journal of clinical oncology. 19(2)
To clarify the tolerance and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic or recurrent breast cancer. From January 2008 through to September 2009, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba7e0c64c0f09b19ac6b9b0fab84d94
https://pubmed.ncbi.nlm.nih.gov/23558559
https://pubmed.ncbi.nlm.nih.gov/23558559
Autor:
Yuki, Saito, Yasuhiro, Suzuki, Takuho, Okamura, Banri, Tsuda, Mizuho, Terada, Mayako, Terao, Yutaka, Tokuda
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(4)
Almost all breast cancer patients are treated with chemotherapy, hormone therapy, molecular targeted therapy, radiotherapy, and surgery alone or in combination. It is reasonable and standard to choose a combination according to clinical practice guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::340b6ec64385789ee8e7c298833b8534
https://pubmed.ncbi.nlm.nih.gov/20414016
https://pubmed.ncbi.nlm.nih.gov/20414016
Autor:
Yasuhiro, Suzuki, Yuki, Saito, Mayako, Terao, Mizuho, Terada, Toru, Morioka, Banri, Tsuda, Takuho, Okamura, Naoki, Niikura, Yutaka, Tokuda
Publikováno v:
The Tokai journal of experimental and clinical medicine. 35(4)
We describe a patient with human epidermal growth factor receptor type 2 (HER2/c-erbB-2)-positive metastatic breast cancer who survived for approximately 6 years after the initiation of combination therapy with trastuzumab and varying types of chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c77625f2314e8ebc862f2a76044a0f64
https://pubmed.ncbi.nlm.nih.gov/21319046
https://pubmed.ncbi.nlm.nih.gov/21319046
Autor:
Yasuhiro Suzuki, Mizuho Terada, Tang Xiaoyan, Nobue Kumaki, Banri Tuda, Risa Oshitanai, Mayako Terao, Shinobu Masuda, Toru Morioka, Yuki Saito, Naoki Niikura, Takuho Okamura, Takayuki Iwamoto, Yutaka Tokuda
Publikováno v:
Clinical Breast Cancer. 14:323-329.e3
Immunohistochemical (IHC) expression of Ki67 has a prognostic and predictive value for breast cancer, and the IHC Ki67 labeling index is estimated by counting the number of positive and negative cells. It has not been clarified whether IHC Ki67 estim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e518f5762966fc58e3cb972aa57e6c2
https://doi.org/10.1016/j.clbc.2013.12.013
https://doi.org/10.1016/j.clbc.2013.12.013
Autor:
Yasuhiro Suzuki, Naoki Niikura, Yutaka Tokuda, Mizuho Terada, Banri Tsuda, Yuki Saito, Risa Oshitanai, Mayako Terao, Toru Morioka, Takuho Okamura, R Ohgiya, Y Kametani
Publikováno v:
Cancer Research. 73:P5-01
In previous decades, numerous attempts have been made to develop therapeutic peptide vaccines for cancer. However, the HLA (Human Leukocyte Antigen) types are limited because most peptide vaccines are specific to the major HLA types of the area. Pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f082cf197d8ab916f98fd2444e8f6930
https://doi.org/10.1158/0008-5472.sabcs13-p5-01-11
https://doi.org/10.1158/0008-5472.sabcs13-p5-01-11
Autor:
Naoki Niikura, Shinobu Masuda, Nobue Kumaki, Tang Xiaoyan, Mizuho Terada, Mayako Terao, Takayuki Iwamoto, Oshitanai, Risa, Morioka, Tom, Banri Tuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda
Publikováno v:
Clinical Breast Cancer; Oct2014, Vol. 14 Issue 5, p323-329, 7p